Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes.
Chen Z, Taubert M, Chen C, Boland J, Dong Q, Bilal M, Dokos C, Wachall B, Wargenau M, Scheidel B, Wiesen MHJ, Schaeffeler E, Tremmel R, Schwab M, Fuhr U. Chen Z, et al. Among authors: wargenau m. Drugs R D. 2024 Jun;24(2):187-199. doi: 10.1007/s40268-024-00466-6. Epub 2024 May 29. Drugs R D. 2024. PMID: 38809387 Free PMC article. Clinical Trial.
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers.
Bilal M, Ullah S, Jaehde U, Trueck C, Zaremba D, Wachall B, Wargenau M, Scheidel B, Wiesen MHJ, Gazzaz M, Chen C, Büsker S, Fuhr U, Taubert M, Dokos C. Bilal M, et al. Among authors: wargenau m. Eur J Clin Pharmacol. 2024 Sep;80(9):1271-1283. doi: 10.1007/s00228-024-03697-3. Epub 2024 May 9. Eur J Clin Pharmacol. 2024. PMID: 38722350 Free PMC article. Clinical Trial.
Validating a composite endpoint for acceptability evaluation of oral drug formulations in the pediatric population: a randomized, open-label, single dose, cross-over study.
Münch J, Schwarzwälder AL, Kloft C, Bosse HM, Wargenau M, Reidemeister S, Klingmann I, Klingmann V. Münch J, et al. Among authors: wargenau m. Front Pharmacol. 2024 Aug 19;15:1436554. doi: 10.3389/fphar.2024.1436554. eCollection 2024. Front Pharmacol. 2024. PMID: 39224774 Free PMC article.
Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Münch J, Sessler I, Bosse HM, Wargenau M, Dreesen JD, Loforese G, Webb NJA, Sivasubramanian R, Reidemeister S, Lustenberger P, Klingmann V. Münch J, et al. Among authors: wargenau m. Pharmaceutics. 2023 Jun 14;15(6):1729. doi: 10.3390/pharmaceutics15061729. Pharmaceutics. 2023. PMID: 37376177 Free PMC article.
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
Dachs TM, Duca F, Rettl R, Binder-Rodriguez C, Dalos D, Ligios LC, Kammerlander A, Grünig E, Pretsch I, Steringer-Mascherbauer R, Ablasser K, Wargenau M, Mascherbauer J, Lang IM, Hengstenberg C, Badr-Eslam R, Kastner J, Bonderman D. Dachs TM, et al. Among authors: wargenau m. Eur Heart J. 2022 Sep 21;43(36):3402-3413. doi: 10.1093/eurheartj/ehac389. Eur Heart J. 2022. PMID: 35909264 Free PMC article. Clinical Trial.
Blood glucose response after oral lactulose intake in type 2 diabetic individuals.
Pieber TR, Svehlikova E, Mursic I, Esterl T, Wargenau M, Sartorius T, Pauly L, Schwejda-Guettes S, Neumann A, Faerber V, Stover JF, Gaigg B, Kuchinka-Koch A. Pieber TR, et al. Among authors: wargenau m. World J Diabetes. 2021 Jun 15;12(6):893-907. doi: 10.4239/wjd.v12.i6.893. World J Diabetes. 2021. PMID: 34168736 Free PMC article.
31 results